Atlas Trials

T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Clinical trial NCT01078337 · COMPLETED

Trial details

NCT number
NCT01078337
Sponsor
Stanford University
Status
COMPLETED
Study type
OBSERVATIONAL
Leukemia, Lymphocytic, Acute
Start date
2002-11-01
Primary completion
2007-10-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.